Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.005 AUD
−19.12 M AUD
0.00 AUD
5.20 B
About ALTERITY THERAPEUTICS LIMITED
Sector
CEO
David A. Stamler
Headquarters
Melbourne
Website
Founded
1997
ISIN
AU0000043945
FIGI
BBG000CDZM28
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ATH is 0.005 AUD — it has decreased by −28.57% in the past 24 hours. Watch ALTERITY THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ALTERITY THERAPEUTICS LIMITED stocks are traded under the ticker ATH.
ATH stock has fallen by −16.67% compared to the previous week, the month change is a 66.67% rise, over the last year ALTERITY THERAPEUTICS LIMITED has showed a −28.57% decrease.
We've gathered analysts' opinions on ALTERITY THERAPEUTICS LIMITED future price: according to them, ATH price has a max estimate of 0.03 AUD and a min estimate of 0.03 AUD. Watch ATH chart and read a more detailed ALTERITY THERAPEUTICS LIMITED stock forecast: see what analysts think of ALTERITY THERAPEUTICS LIMITED and suggest that you do with its stocks.
ATH stock is 40.00% volatile and has beta coefficient of 3.11. Track ALTERITY THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is ALTERITY THERAPEUTICS LIMITED there?
Today ALTERITY THERAPEUTICS LIMITED has the market capitalization of 29.26 M, it has increased by 20.00% over the last week.
Yes, you can track ALTERITY THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
ALTERITY THERAPEUTICS LIMITED is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
ATH net income for the last half-year is −12.62 M AUD, while the previous report showed −6.51 M AUD of net income which accounts for −93.88% change. Track more ALTERITY THERAPEUTICS LIMITED financial stats to get the full picture.
No, ATH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 10.00 employees. See our rating of the largest employees — is ALTERITY THERAPEUTICS LIMITED on this list?
Like other stocks, ATH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALTERITY THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALTERITY THERAPEUTICS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALTERITY THERAPEUTICS LIMITED stock shows the neutral signal. See more of ALTERITY THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.